Australian study looks to improve supply chain:
This article was originally published in Clinica
The Medical Industry Association of Australia is to co-sponsor a study which aims to improve the efficiency of the medical device supply chain to hospitals. A steering committee has been set up to oversee the study and take responsibility for getting suppliers, distributors and hospitals to co-operate, such as in providing cost data. The first objective will be to assess where the major inefficiencies lie. Once existing costs have been quantified, options for improving efficiency will be assessed. The study, which will also draw on overseas experience, is expected to be completed by early 1999 and the recommendations will be implemented through a series of pilot projects.
You may also be interested in...
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
In second letter this year targeting email communications, OPDP says that putting the methotrexate oral solution’s risk information below the signature block does not offer ‘prominence and readability’ comparable to the information on the drug’s effectiveness for the treatment of acute lymphoblastic leukemia that was in the body of the email.